Health ❯ Addiction

Alcohol Use Disorder

Treatment Options Treatment Prevention Strategies Heavy Drinking Binge Drinking Health Risks Recovery Biological Mechanisms GLP-1 Medications Assessment Tools Medications Demographics Health Impacts Myths and Facts GLP-1 Drugs Risk Assessment Genetic Factors Gene Expression Drinking Patterns Withdrawal Symptoms Societal Impact Treatment Studies Long-term Effects Public Health Issues Alcohol-Associated Hepatitis Risk Factors Perception of Consumption Gut-Brain Axis Pharmacological Treatments Medication Effects Treatment Methods Screening Tools Family Impact Moderate Drinking Episodic Heavy Drinking

New Studies and Policy Pilots Push GLP‑1 Drugs into Wider Use as Cost and Safety Questions Grow

Evidence that semaglutide and tirzepatide are linked to fewer alcohol-related hospital admissions and new UK and U.S. access programs have expanded use while leaving budget, safety and long-term benefit concerns unresolved.

Heavy Lifetime Drinking Raises Colorectal Cancer Risk, Especially Rectal Cancer

Heavy Drinking Tied to Earlier, Larger Brain Bleeds, Study Finds

Major Study Finds No Safe Level of Alcohol for Dementia Risk

Study Links Parental Liver-Disease Death to Double the Risk of Alcohol-Associated Hepatitis

Mark Coleman Uses ‘The Smashing Machine’ Biopic to Champion Sobriety Ahead of October Release